THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 37 filers reported holding THE ONCOLOGY INSTITUTE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,200 | +175.7% | 78,000 | +8.3% | 0.00% | – |
| Q2 2023 | $39,614 | -86.1% | 72,000 | -82.8% | 0.00% | – |
| Q1 2023 | $284,461 | -79.4% | 419,621 | -49.9% | 0.00% | – |
| Q4 2022 | $1,382,624 | +3.6% | 837,954 | +190.8% | 0.00% | – |
| Q3 2022 | $1,334,000 | +32.7% | 288,127 | +45.1% | 0.00% | – |
| Q2 2022 | $1,005,000 | +352.7% | 198,627 | +538.7% | 0.00% | – |
| Q1 2022 | $222,000 | – | 31,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parian Global Management LP | 183,828 | $930,000 | 4.26% |
| Velan Capital Investment Management LP | 600,000 | $3,036,000 | 3.08% |
| Triatomic Management LP | 365,679 | $1,850,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,383,099 | $17,118,000 | 0.35% |
| Redmile Group, LLC | 1,736,116 | $8,785,000 | 0.34% |
| Saba Capital Management, L.P. | 367,292 | $1,858,000 | 0.02% |
| FMR LLC | 12,000,078 | $60,720,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 6,251 | $31,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 470 | $2,000 | 0.00% |
| NORTHERN TRUST CORP | 143,921 | $729,000 | 0.00% |